In this respect, studies have yielded inconclusive results regarding genetic variation in CNR1 being associated with TD [145,146] but significantly increased CSF levels of several endocannabinoids as well as AA were reported in TD patients compared with controls [147]. This evidence concerns the gene CNR1 and thanatophoric dysplasia.